Literature DB >> 34993124

Unexpected discovery of prostatic diffuse large B-cell lymphoma after thulium laser vaporization in a patient with Waldenstrom macroglobulinemia.

Jialei Wang1, Huilei Yan1, Shuyan Tian2, Lei Qin3, Yunbo Ma1.   

Abstract

Entities:  

Year:  2022        PMID： 34993124      PMCID： PMC8666792          DOI： 10.21037/qims-20-1319

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  26 in total

Review 1.  Diffuse large B-cell lymphoma of the prostate.

Authors:  Joshua I Warrick; Scott R Owens; Scott A Tomlins
Journal:  Arch Pathol Lab Med       Date:  2014-10       Impact factor: 5.534

2.  Cutaneous macroglobulinosis as the initial presentation of Waldenström macroglobulinemia in a patient with a history of diffuse large B-cell lymphoma.

Authors:  Aria Shakeri; Benjamin H Kaffenberger; Alejandro A Gru
Journal:  J Cutan Pathol       Date:  2018-09-07       Impact factor: 1.587

3.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Authors:  Steven P Treon; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Patricia Sheehy; Robert J Manning; Christopher J Patterson; Christina Tripsas; Luca Arcaini; Geraldine S Pinkus; Scott J Rodig; Aliyah R Sohani; Nancy Lee Harris; Jason M Laramie; Donald A Skifter; Stephen E Lincoln; Zachary R Hunter
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

Review 4.  Is There Use for FDG-PET in Prostate Cancer?

Authors:  Hossein Jadvar
Journal:  Semin Nucl Med       Date:  2016-09-03       Impact factor: 4.446

Review 5.  Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment.

Authors:  Yang Liu; Stefan Klaus Barta
Journal:  Am J Hematol       Date:  2019-05       Impact factor: 10.047

Review 6.  PET in prostate and bladder tumors.

Authors:  Sze Ting Lee; Nathan Lawrentschuk; Andrew M Scott
Journal:  Semin Nucl Med       Date:  2012-07       Impact factor: 4.446

7.  Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma.

Authors:  Gerhard Held; Niels Murawski; Marita Ziepert; Jochen Fleckenstein; Viola Pöschel; Carsten Zwick; Jörg Bittenbring; Mathias Hänel; Sibylla Wilhelm; Jörg Schubert; Norbert Schmitz; Markus Löffler; Christian Rübe; Michael Pfreundschuh
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

8.  Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume center.

Authors:  Dong Hoon Lee; Doo Yong Chung; Kwang-suk Lee; In Kyong Kim; Koon Ho Rha; Young Deuk Choi; Byung Ha Chung; Sung Joon Hong; Jang Hwan Kim
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

9.  From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation.

Authors:  C Jiménez; S Alonso-Álvarez; M Alcoceba; G R Ordóñez; M García-Álvarez; M I Prieto-Conde; M C Chillón; A Balanzategui; R Corral; L A Marín; N C Gutiérrez; N Puig; M E Sarasquete; M González; R García-Sanz
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

Review 10.  FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview.

Authors:  Conrad-Amadeus Voltin; Jasmin Mettler; Jirka Grosse; Markus Dietlein; Christian Baues; Christine Schmitz; Peter Borchmann; Carsten Kobe; Dirk Hellwig
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.